|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:drug
|
|
gptkbp:approvalYear
|
1993
|
|
gptkbp:ATCCode
|
gptkb:L01BB04
|
|
gptkbp:brand
|
gptkb:Leustatin
gptkb:Mavenclad
|
|
gptkbp:CASNumber
|
gptkb:4291-63-8
|
|
gptkbp:category
|
antineoplastic agent
immunosuppressant
|
|
gptkbp:chemicalFormula
|
C10H12ClN5O3
|
|
gptkbp:contraindication
|
pregnancy
immunodeficiency
active infection
|
|
gptkbp:developer
|
gptkb:EMD_Serono
gptkb:Merck_KGaA
|
|
gptkbp:discoveredBy
|
gptkb:Dennis_A._Carson
|
|
gptkbp:eliminationHalfLife
|
5.6-19.7 hours
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:hasSMILES
|
Clc1ncnc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
cladribine
|
|
gptkbp:KEGGID
|
D00297
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
purine analog
inhibits DNA synthesis
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:pregnancyCategory
|
contraindicated
|
|
gptkbp:PubChem_CID
|
2019
CHEMBL1387
DB00242
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
|
|
gptkbp:sideEffect
|
gptkb:lymphopenia
fever
nausea
headache
infections
|
|
gptkbp:synonym
|
gptkb:2-chloro-2'-deoxyadenosine
gptkb:2-chlorodeoxyadenosine
|
|
gptkbp:UNII
|
8M6C7Z6Z1L
|
|
gptkbp:usedFor
|
gptkb:hairy_cell_leukemia
multiple sclerosis
|
|
gptkbp:year_of_EMA_approval
|
2017
|
|
gptkbp:bfsParent
|
gptkb:multidrug_resistance-associated_protein_1
gptkb:Mavenclad
gptkb:systemic_mastocytosis
|
|
gptkbp:bfsLayer
|
6
|